Growing Public Interest in Mitochondrial Function Testing for Wellness and Longevity

Public interest in mitochondrial function testing is on the rise as individuals seek to improve their overall wellness and extend their lifespan. Once a concern primarily for elite athletes and biohacking enthusiasts, mitochondrial health is now gaining attention among the general population. This shift is partly due to promising research into editing mitochondrial DNA to restore function, offering hope for those with conditions linked to mitochondrial dysfunction. Companies such as Clene Inc. (NASDAQ: CLNN) are at the forefront of biomedical research and development in this area, contributing to the growing accessibility and understanding of mitochondrial health.